BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19824892)

  • 21. A potential role for 5-androstene-3β,7β,17β-triol in obesity and metabolic syndrome.
    Auci DL; Ahlem CN; Kennedy MR; Page TM; Reading CL; Frincke JM
    Obesity (Silver Spring); 2011 Apr; 19(4):806-11. PubMed ID: 20847733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of some 17-picolyl and 17-picolinylidene androst-5-ene derivatives.
    Gasi KM; Brenesel MDj; Djurendić EA; Sakac MN; Canadi JJ; Daljev JJ; Armbruster T; Andrić S; Sladić DM; Bozić TT; Novaković IT; Juranić ZD
    Steroids; 2007 Jan; 72(1):31-40. PubMed ID: 17118415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of 7-substituted-5-androstene derivatives promoted by SmI2.
    Gu Q; Zheng YH; Li YC
    Steroids; 2006 Feb; 71(2):96-101. PubMed ID: 16289174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-activity relationships in 4- and 5-androstene: 3beta-acetoxy-17-methyl-17-oxo-16,17-seco-5-androstene-16-carbonitrile and 17-methyl-3,17-dioxo-16,17-seco-4-androstene-16-carbonitrile.
    Lazar D; Klisurić O; Stanković S; Penov-Gasi K; Djurendić E; Kovacević R
    Acta Crystallogr C; 2004 Sep; 60(Pt 9):o671-3. PubMed ID: 15345852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of type 2 17beta-hydroxysteroid dehydrogenase by estradiol derivatives bearing a lactone on the D-ring: structure-activity relationships.
    Bydal P; Auger S; Poirier D
    Steroids; 2004 May; 69(5):325-42. PubMed ID: 15219411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transformations of testosterone and related steroids in Absidia glauca culture.
    Huszcza E; Dmochowska-Gladysz J
    J Basic Microbiol; 2003; 43(2):113-20. PubMed ID: 12746853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dehydroepiandrosterone 7alpha- and 7beta-hydroxylation in mouse brain microsomes. Effects of cytochrome P450 inhibitors and structure-specific inhibition by steroid hormones.
    Doostzadeh J; Cotillon AC; Morfin R
    J Neuroendocrinol; 1997 Dec; 9(12):923-8. PubMed ID: 9468017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The metabolism of [4-14C]5-androstene-3 beta, 17 beta-diol by normal human skin in vitro.
    Faredin I; Tóth I
    Acta Med Acad Sci Hung; 1975; 32(2):139-52. PubMed ID: 1235221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 7-Hydroxylated derivatives of dehydroepiandrosterone in the human ventricular cerebrospinal fluid.
    Starka L; Hill M; Kancheva R; Novak Z; Chrastina J; Pohanka M; Morfin R
    Neuro Endocrinol Lett; 2009; 30(3):368-72. PubMed ID: 19855361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pituitary metabolism of 5alpha-androstane-3beta-17beta-diol: intense and rapid conversion into 5alpha-androstane-3beta,6alpha,17beta-triol and 5alpha-androstane-3beta,7alpha, 17beta-triol.
    Guiraud JM; Morfin R; Ducouret B; Samperez S; Jouan P
    Steroids; 1979 Sep; 34(3):241-8. PubMed ID: 494365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3Beta-alkyl-androsterones as inhibitors of type 3 17beta-hydroxysteroid dehydrogenase: inhibitory potency in intact cells, selectivity towards isoforms 1, 2, 5 and 7, binding affinity for steroid receptors, and proliferative/antiproliferative activities on AR+ and ER+ cell lines.
    Ngatcha BT; Laplante Y; Labrie F; Luu-The V; Poirier D
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):225-32. PubMed ID: 16359782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 7alpha-Iodo and 7alpha-fluoro steroids as androgen receptor-mediated imaging agents.
    Labaree DC; Hoyte RM; Nazareth LV; Weigel NL; Hochberg RB
    J Med Chem; 1999 Jun; 42(11):2021-34. PubMed ID: 10354410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and antiproliferative activity of some androstene oximes and their O-alkylated derivatives.
    Acharya PC; Bansal R
    Arch Pharm (Weinheim); 2014 Mar; 347(3):193-9. PubMed ID: 24343881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The human cytochrome P4507B1: catalytic activity studies.
    Kim SB; Chalbot S; Pompon D; Jo DH; Morfin R
    J Steroid Biochem Mol Biol; 2004 Dec; 92(5):383-9. PubMed ID: 15698543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and quantification of metabolites common to 17alpha-methyltestosterone and mestanolone in horse urine.
    Yamada M; Aramaki S; Okayasu T; Hosoe T; Kurosawa M; Kijima-Suda I; Saito K; Nakazawa H
    J Pharm Biomed Anal; 2007 Sep; 45(1):125-133. PubMed ID: 17709226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular targets for 17α-ethynyl-5-androstene-3β,7β,17β-triol, an anti-inflammatory agent derived from the human metabolome.
    Reading CL; Frincke JM; White SK
    PLoS One; 2012; 7(2):e32147. PubMed ID: 22384159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biotransformation of a potent anabolic steroid, mibolerone, with Cunninghamella blakesleeana, C. echinulata, and Macrophomina phaseolina, and biological activity evaluation of its metabolites.
    Siddiqui M; Ahmad MS; Wahab AT; Yousuf S; Fatima N; Naveed Shaikh N; Rahman AU; Choudhary MI
    PLoS One; 2017; 12(2):e0171476. PubMed ID: 28234904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CYP7B1-mediated metabolism of dehydroepiandrosterone and 5alpha-androstane-3beta,17beta-diol--potential role(s) for estrogen signaling.
    Pettersson H; Holmberg L; Axelson M; Norlin M
    FEBS J; 2008 Apr; 275(8):1778-89. PubMed ID: 18331353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and antitumor activity of cholest-4 alpha-methyl-7-en-3beta-ol derivatives.
    He L; Liu Y; Shi J; Pei Q
    Steroids; 2006 Jun; 71(6):476-83. PubMed ID: 16504229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro potentiation of lymphocyte activation by dehydroepiandrosterone, androstenediol, and androstenetriol.
    Padgett DA; Loria RM
    J Immunol; 1994 Aug; 153(4):1544-52. PubMed ID: 8046232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.